Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease

Blood

Volumn 103, Issue 12, 2004, Pages 4681-4684

  Ertault Daneshpouy, Marjan ^b   Leboeuf, Christophe ^b   Lemann, Marc ^b   Bouhidel, Fatiha ^b   Ades, Lionel ^b   Gluckman, Eliane ^b   Socié, Gérard ^a   Janin, Anne ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLOIMMUNITY; ARTICLE; BLEEDING; CAPILLARY BASEMENT MEMBRANE; CELL ULTRASTRUCTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; EXTRAVASATION; FEMALE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; MALE; PERICAPILLARY HEMORRHAGE; PRIORITY JOURNAL; TRANSPLANTATION;

EID: 2942593697     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-05-1548     Document Type: Article

References (20)

1. Nurnberger W, Michelmann I, Burdach S, et al. Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications. Ann Hematol. 1998;76:61-65.
2. Collins PW, Gutteridge CN, O'Driscoll A, et al. Von Willebrand factor as a marker of endothelial cell activation following BMT. Bone Marrow Transplant. 1992;10:499-506.
3. Salat C, Holler E, Kolb HJ, et al. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease. Bone Marrow Transplant. 1997;19:909-914.
4. Takatsuka H, Takemoto Y, Yamada S, et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant. 2000;26:419-426.
5. Eissner G, Kohlhuber F, Grell M, et al. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood. 1995;86:4184-4193.
6. Piguet PF, Grau GE, Allet B, et al. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease. J Exp Med. 1987;166:1280-1289.
7. Facon T, Jouet JP, Noel-Walter MP, et al. Involvement of TNF-alpha secreting macrophages in lethal forms of human graft-versus-host disease. Bone Marrow Transplant. 1997;20:511-515.
8. Janin A, Deschaumes C, Daneshpouy M, et al. CD95 engagement induces disseminated endothelial cell apoptosis in vivo: immunopathologic implications. Blood. 2002;99:2940-2947.
9. Biedermann BC, Sahner S, Gregor M, et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet. 2002;359:2078-2083.
10. Daneshpouy M, Socie G, Lemann M, et al. Activated eosinophils in upper gastrointestinal tract of patients with graft-versus-host disease. Blood. 2002;99:3033-3040.
11. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295-304.
12. Sale GE, Shulman HM, McDonald GB, Thomas ED. Gastrointestinal graft-versus-host disease in man: a clinicopathologic study of the rectal biopsy. Am J Surg Pathol. 1979;3:291-299.
13. Epstein RJ, McDonald GB, Sale GE, Shulman HM, Thomas ED. The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology. 1980;78:764-771.
14. Weisdorf DJ, Snover DC, Haake R, et al. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood. 1990;76:624-629.
15. Roy J, Platt JL, Weisdorf DJ. The immunopathology of upper gastrointestinal acute graft-versus-host disease: lymphoid cells and endothelial adhesion molecules. Transplantation. 1993;55:572-578.
16. Meehan SM, McCluskey RT, Pascual M, et al. Cytotoxicity and apoptosis in human renal allografts: identification, distribution, and quantitation of cells with a cytotoxic granule protein GMP-17 (TIA-1) and cells with fragmented nuclear DNA. Lab Invest. 1997;76:639-649.
17. Dumler JS, Beschomer WE, Farmer ER, Di Gennaro KA, Saral R, Santos GW. Endothelial-cell injury in cutaneous acute graft-versus-host disease. Am J Pathol. 1989;135:1097-1103.
18. Snover DC, Weisdorf SA, Ramsay NK, McGlave P, Kersey JH. Hepatic graft versus host disease: a study of the predictive value of liver biopsy in diagnosis. Hepatology. 1984;4:123-130.
19. Janin-Mercier A, Saurat JH, Bourges M, Sohier J, Jean LD, Gluckman E. The lichen planus like and sclerotic phases of the graft versus host disease in man: an ultrastructural study of six cases. Acta Derm Venereol. 1981;61:187-193.
20. Socie G, Mary JY, Lemann M, et al. Graft-versus-host disease of the gastro-intestinal tract in humans: TNF and Fas expression; prognostic value of infiltrating neutrophils. Blood. 2004;103:50-57.